Patents by Inventor Hans-Jurgen Gutke

Hans-Jurgen Gutke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8461120
    Abstract: The invention features novel macrocyclic compounds, methods of making the compounds, pharmaceutical compositions including the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: June 11, 2013
    Assignee: Synovo GmbH
    Inventors: Hans-Jurgen Gutke, Michael Burnet, Jan-Hinrich Guse
  • Patent number: 8357506
    Abstract: This invention features a method of identifying a compound useful for enhancing efficacy of a therapeutic agent. The method includes incubating a compound in blood cells; separating immune cells from erythrocytic cells; and determining the ratio of the concentration of the compound in the immune cells to the concentration of the compound in the erythrocytic cells; wherein the compound comprises a transportophore and a therapeutic agent, in which the transportophore is covalently bonded to the therapeutic agent via a bond or a linker.
    Type: Grant
    Filed: June 12, 2008
    Date of Patent: January 22, 2013
    Inventors: Michael Burnet, Jan-Hinrich Guse, Gene Kim, Albert Beck, Georgia Tsotsou, Irina Droste-Borel, Laurence Barker, Michael Wolff, Hans-Jurgen Gutke
  • Publication number: 20110028417
    Abstract: The invention features novel macrocyclic compounds, methods of making the compounds, pharmaceutical compositions including the compounds, and methods of treatment using the compounds.
    Type: Application
    Filed: July 30, 2010
    Publication date: February 3, 2011
    Applicant: Synovo GmbH
    Inventors: Hans-Jurgen Gutke, Michael Burnet, Jan-Hinrich Guse
  • Patent number: 7767797
    Abstract: The invention features novel macrocyclic compounds, methods of making the compounds, pharmaceutical compositions including the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: August 3, 2010
    Assignee: Synovo GmbH
    Inventors: Hans-Jurgen Gutke, Michael Burnet, Jan-Hinrich Guse
  • Publication number: 20090221697
    Abstract: The present invention relates to macrolide conjugates of pyrrolizine and indolizine derivatives with macrocyclic antibiotics and derivatives thereof. The macrolide conjugates are potent inhibitors of 5-lipoxygenase and cyclooxygenase and are therefore suitable to treat disorders of the rheumatic type and to prevent allergically induced diseases. The macrolide conjugates have significantly enhanced potency and efficacy.
    Type: Application
    Filed: July 26, 2006
    Publication date: September 3, 2009
    Applicant: MERCKLE GMBH
    Inventors: Stefan Laufer, Wolfgang Albrecht, Michael Burnet, Hans-Jürgen Gutke
  • Patent number: 7579324
    Abstract: This invention features a compound of the following formula: T-(-L-C)m, T is a transportophore, L is a bond or a linker having a molecular weight up to 240 dalton, C is a non-antibiotic therapeutic agent, and m is 1, 2, 3, 4, 5, 6, 7, or 8, in which the transportophore has an immune selectivity ratio of at least 2, the transportophore is covalently bonded to the non-antibiotic therapeutic agent via the bond or the linker, and the compound has an immune selectivity ratio of at least 2.
    Type: Grant
    Filed: February 14, 2003
    Date of Patent: August 25, 2009
    Assignee: c-a-i-r biosciences GmbH
    Inventors: Michael Burnet, Jan-Hinrich Guse, Hans-Jurgen Gutke, Albert Beck, Georgia Tsotsou, Irina Droste-Borel, Jeannette Reichert, Kattie Luyten, Maximilian Busch, Michael Wolff, Moussa Khobzaoui, Simona Margutti, Thomas Meindl, Gene Kim, Laurence Barker
  • Publication number: 20090093014
    Abstract: This invention features a method of identifying a compound useful for enhancing efficacy of a therapeutic agent. The method includes incubating a compound in blood cells; separating immune cells from erythrocytic cells; and determining the ratio of the concentration of the compound in the immune cells to the concentration of the compound in the erythrocytic cells; wherein the compound comprises a transportophore and a therapeutic agent, in which the transportophore is covalently bonded to the therapeutic agent via a bond or a linker.
    Type: Application
    Filed: June 12, 2008
    Publication date: April 9, 2009
    Inventors: Michael Burnet, Jan-Hinrich Guse, Gene Kim, Albert Beck, Georgia Tsotsou, Irina Droste-Borel, Laurence Barker, Michael Wolff, Hans-Jurgen Gutke
  • Publication number: 20080145343
    Abstract: This invention features a method of identifying a compound useful for enhancing efficacy of a therapeutic agent. The method includes incubating a compound in blood cells; separating immune cells from erythrocytic cells; and determining the ratio of the concentration of the compound in the immune cells to the concentration of the compound in the erythrocytic cells; wherein the compound comprises a transportophore and a therapeutic agent, in which the transportophore is covalently bonded to the therapeutic agent via a bond or a linker.
    Type: Application
    Filed: August 23, 2007
    Publication date: June 19, 2008
    Inventors: Michael Burnet, Jan-Hinrich Guse, Gene Kim, Hans-Jurgen Gutke, Albert Beck, Georgia Tsotsou, Irina Droste-Borel, Laurence Barker, Michael Wolf
  • Publication number: 20050171342
    Abstract: This invention features a compound of the following formula: T-(-L-C)m, T is a transportophore, L is a bond or a linker having a molecular weight up to 240 dalton, C is a non-antibiotic therapeutic agent, and m is 1, 2, 3, 4, 5, 6, 7, or 8, in which the transportophore has an immune selectivity ratio of at least 2, the transportophore is covalently bonded to the non-antibiotic therapeutic agent via the bond or the linker, and the compound has an immune selectivity ratio of at least 2.
    Type: Application
    Filed: February 14, 2003
    Publication date: August 4, 2005
    Inventors: Michael Burnet, Jan-Hinrich Guse, Hans-Jurgen Gutke, Albert Beck, Georgia Tsotsou, Irina Droste-Borel, Jeannette Reichert, Kattie Luyten, Maximilian Busch, Michael Wolff, Moussa Khobzaoui, Simona Margutti, Thomas Meindl, Gene Kim, Laurent Barker
  • Publication number: 20040186063
    Abstract: This invention features a compound of the following formula:
    Type: Application
    Filed: August 20, 2003
    Publication date: September 23, 2004
    Inventors: Hans-Jurgen Gutke, Christian Flohr, Albert Beck, Simona Margutti, Mary Eggers, Jan-Hinrich Guse, Moussa Khobzaoui, Michael Burnet
  • Publication number: 20040087517
    Abstract: This invention features a compound of the following formula:
    Type: Application
    Filed: February 14, 2003
    Publication date: May 6, 2004
    Inventors: Michael Burnet, Jan-Hinrich Guse, Hans-Jurgen Gutke, Albert Beck, Georgia Tsotsou, Irina Droste-Borel, Jeannette Reichert, Kattie Luyten, Maximilian Busch, Michael Wolff, Moussa Khobzaoui, Simona Margutti, Thomas Meindl, Gene Kim, Laurence Barker
  • Publication number: 20040005641
    Abstract: This invention features a method of identifying a compound useful for enhancing efficacy of a therapeutic agent. The method includes incubating a compound in blood cells; separating immune cells from erythrocytic cells; and determining the ratio of the concentration of the compound in the immune cells to the concentration of the compound in the erythrocytic cells; wherein the compound comprises a transportophore and a therapeutic agent, in which the transportophore is covalently bonded to the therapeutic agent via a bond or a linker.
    Type: Application
    Filed: February 14, 2003
    Publication date: January 8, 2004
    Inventors: Michael Burnet, Jan-Hinrich Guse, Gene Kim, Hans-Jurgen Gutke, Albert Beck, Georgia Tsotsou, Irina Droste-Borel, Laurence Barker, Michael Wolff